| |
| |
|
| Insider
Information: |
Loberg Michael D |
| Relationship: |
Director |
| City: |
Bedford |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
9,138 |
|
|
Indirect Shares
|
81,790 |
|
|
| Direct
Value |
$110,000 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
90,928 |
|
|
| Total
Value |
$110,000 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
AMAG Pharmaceuticals Inc |
AMAG |
Director |
2006-06-08 |
8,000 |
2006-06-07 |
0 |
Premium* |
|
|
Arqule Inc |
ARQL |
Director |
2020-01-16 |
0 |
2007-08-17 |
0 |
Premium* |
|
|
Igm Biosciences, Inc. |
IGMS |
Director |
2023-09-29 |
1,138 |
2023-09-29 |
81,790 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
262 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARQL |
Arqule Inc |
Director |
– • – |
2008-04-10 |
4 |
B |
$3.88 |
$497 |
D/D |
128 |
2,719 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2008-05-07 |
4 |
B |
$3.72 |
$498 |
D/D |
134 |
2,853 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2008-05-15 |
4 |
B |
$4.10 |
$996 |
D/D |
243 |
3,096 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2008-05-29 |
4 |
B |
$4.11 |
$1,874 |
D/D |
456 |
3,552 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2008-06-05 |
4 |
B |
$4.35 |
$496 |
D/D |
114 |
3,666 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2008-07-11 |
4 |
B |
$3.78 |
$499 |
D/D |
132 |
3,798 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2008-07-17 |
4 |
B |
$3.98 |
$999 |
D/D |
251 |
4,049 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2008-08-07 |
4 |
B |
$3.49 |
$499 |
D/D |
143 |
4,192 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2008-08-18 |
4 |
B |
$3.58 |
$1,872 |
D/D |
523 |
4,715 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2008-09-12 |
4 |
B |
$3.45 |
$1,998 |
D/D |
579 |
5,294 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2008-10-09 |
4 |
B |
$2.25 |
$500 |
D/D |
222 |
5,516 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2008-10-27 |
4 |
B |
$1.90 |
$999 |
D/D |
526 |
6,042 |
2.31 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2006-06-07 |
4 |
OE |
$3.05 |
$214,200 |
D/D |
31,500 |
6,500 |
|
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2006-06-08 |
4 |
OE |
$3.05 |
$159,465 |
D/D |
31,500 |
8,000 |
|
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2021-04-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
300 |
12,696 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2021-07-08 |
4 |
GA |
$0.00 |
$0 |
I/I |
300 |
12,996 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2008-11-13 |
4 |
B |
$2.87 |
$27,850 |
D/D |
9,710 |
15,752 |
2.39 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2008-11-14 |
4 |
B |
$2.84 |
$5,108 |
D/D |
1,800 |
17,552 |
2.39 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-04-01 |
4 |
B |
$23.00 |
$499,997 |
I/I |
21,739 |
21,739 |
2.1 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-04-08 |
4 |
GA |
$0.00 |
$0 |
I/I |
533 |
22,272 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-07-18 |
4 |
GA |
$0.00 |
$0 |
I/I |
533 |
22,805 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-09-27 |
4 |
B |
$19.99 |
$10,137 |
I/I |
507 |
23,312 |
2.1 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-09-28 |
4 |
B |
$20.97 |
$129,403 |
I/I |
6,172 |
29,484 |
2.1 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2019-09-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
30,264 |
|
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2019-09-18 |
4 |
B |
$18.57 |
$92,867 |
D/D |
5,000 |
35,264 |
2.39 |
- |
|
262 Records found
|
|
Page 3 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
